Simple Summary Although gradually declining in incidence, gastric cancer has remained a
substantial disease burden and an epidemiological challenge worldwide. In this review …

Background Over the past four decades, the Chinese government has conducted three
surveys on the distribution of causes of death and built cancer registration. In order to shine …

Background: Population-based esophageal cancer (EC) screening trials and programs have
been conducted in China for decades; however, screening strategies have been adopted in …

Over a billion people across the world experience a high rate of missed disease diagnosis,
an issue that highlights the need for diagnostic tools showing increased accuracy and …

In 2020, stomach cancer was the fifth most commonly diagnosed cancer and the fourth
leading cause of cancer-related death worldwide. Due to the relatively huge population …

In the past decade, the Chinese government has committed to promoting gastric cancer
(GC) prevention and control 1, 2. GC is a major malignancy globally, and nearly half of GC …

Background The spatiotemporal epidemiological evidence supporting joint endoscopic
screening for esophageal cancer (EC) and gastric cancer (GC) remains limited. This study …

Although messenger RNA translation is tightly regulated to preserve protein synthesis and
cellular homeostasis, chronic exposure to interferon‐γ (IFN‐γ) in several cancers can lead to …

The benefits of gastric cancer screening are related to age and comorbidity status, but
reliable estimates are lacking in China. This study aimed to estimate the benefits and …

Purpose This study aimed to investigate the willingness of Chinese adults aged 40 years
and older to undergo gastroscopy for gastric cancer (GC) screening during the COVID-19 …